Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL238312 | 1.00 | LMNA (0.68) | LMNABLMMEN1CYP3A4ALOX15 | |
| SCHEMBL1193294 | 1.00 | LMNA (0.68) | LMNABLMMEN1CYP3A4ALOX15 | |
| SCHEMBL632397 | 0.94 | LMNA (0.68) | LMNABLMMEN1CYP3A4ALOX15 | |
| SCHEMBL3337422 | 0.89 | LMNA (0.68) | LMNABLMMEN1CYP3A4ALOX15 | |
| SCHEMBL7269036 | 0.86 | LMNA (0.74) | LMNABLMMEN1CYP3A4ALOX15 | |
| SCHEMBL10945252 | 0.86 | LMNA (0.74) | LMNABLMMEN1CYP3A4ALOX15 | |
| SCHEMBL10991364 | 0.85 | LMNA (0.53) | LMNABLMMEN1CYP3A4ALOX15 | |
| SCHEMBL20928 | 0.85 | LMNA (0.93) | LMNABLMMEN1CYP3A4ALOX15 | |
| SCHEMBL538230 | 0.85 | LMNA (0.93) | LMNABLMMEN1CYP3A4ALOX15 | |
| SCHEMBL8672325 | 0.85 | LMNA (0.93) | LMNABLMMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021086689-A1 | 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOF | PRIME REACH TRADING LIMITED (WS) | 2021-05-06 | — | — | WO | claimed |
| US-20150141502-A1 | INHIBITION OF LEUKEMIC STEM CELLS BY PP2A ACTIVATING AGENTS | Ohio State Innvation Foundation (US) | 2015-05-21 | — | — | US | claimed |
| WO-2013181488-A2 | INHIBITION OF LEUKEMIC STEM CELLS BY PP2A ACTIVATING AGENTS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2013-12-05 | — | — | WO | claimed |
| EP-2418948-B1 | ANTIADHESION AGENTS | UNIV OHIO STATE RES FOUND (US) | 2013-09-04 | — | — | EP | claimed |
| EP-2419414-A1 | PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS | The Ohio State University Research Foundation (US) | 2012-02-22 | — | — | EP | claimed |
| EP-2418948-A1 | ANTIADHESION AGENTS | The Ohio State University Research Foundation (US) | 2012-02-22 | — | — | EP | claimed |
| WO-2010121111-A9 | ANTIADHESION AGENTS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2011-12-22 | — | — | WO | claimed |
| US-20100267673-A1 | PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS | THE OHIO SATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-10-21 | — | — | US | claimed |
| US-20100267820-A1 | ANTIADHESION AGENTS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-10-21 | — | — | US | claimed |
| WO-2010121111-A1 | ANTIADHESION AGENTS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-10-21 | — | — | WO | claimed |
| WO-2010120711-A1 | PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-10-21 | — | — | WO | claimed |
| US-4115466-A | ACETYLENIC HYDROCARBONS FROM ACETYLENIC CARBINOLS, ISOMERIZATION | SCM CORPORATION (US) | 1978-09-19 | — | — | US | claimed |
| US-3975446-A | FROM UNSATURATED ALCOHOL, TERTIARY AMINE | SHINETSU CHEMICAL COMPANY (JA) | 1976-08-17 | — | — | US | claimed |
| EP-3837247-B1 | SYNTHESIS OF CHROMANOL DERIVATIVES | BASF SE (DE) | 2024-06-05 | — | — | EP | disclosed |
| CN-110325646-B | Process for preparing (3E, 7E) -Gao Fani acid or (3E, 7E) -Gao Fani acid esters | 巴斯夫欧洲公司 | 2024-02-09 | — | — | CN | disclosed |
| WO-2023238837-A1 | EXOSOME COMPLEX AND MANUFACTURING METHOD THEREOF | JSR株式会社 | 2023-12-14 | — | — | WO | disclosed |
| US-4073813-A | PLATINUM REDUCTION CATALYST, ALDEHYDES, HYDROGEN | RHONE-POULENC INDUSTRIES (FR) | 1978-02-14 | — | — | US | disclosed |
| US-4055575-A | HYDROGENATION, SAPONIFICATION | SCM CORPORATION (US) | 1977-10-25 | — | — | US | disclosed |
| US-4039591-A | 1-ACETOXY-4-CHLORO-3-METHYLBUT-2-ENE | SCM CORPORATION (US) | 1977-08-02 | — | — | US | disclosed |
| US-3975446-A | FROM UNSATURATED ALCOHOL, TERTIARY AMINE | SHINETSU CHEMICAL COMPANY (JA) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267673-A1 | PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS | PPP2CA, PPP2R2A, PPP2R1A | LMNA 3602/4885BLM 4530/4885MEN1 4219/4885 |
| US-20150141502-A1 | INHIBITION OF LEUKEMIC STEM CELLS BY PP2A ACTIVATING AGENTS | PPM1A, PPM1G, PPM1F | LMNA 3971/4885BLM 4068/4885MEN1 1662/4885 |
| US-20100267820-A1 | ANTIADHESION AGENTS | SELE, EPCAM, SELP | LMNA 2725/4885BLM 3727/4885MEN1 1770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.